Login to Your Account

Other News To Note

Wednesday, March 20, 2013
• Stellar Biotechnologies Inc., of Port Hueneme, Calif., submitted a Type IV Biologics Master File to the FDA's Center for Biologics Evaluation and Research for its subunit Keyhole Limpet Hemocyanin (KLH).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription